Skip Nav Destination
Issues
June 2021
-
Cover Image
Cover Image
Cover: Light on the form of Green Tara. Credit: Jewelee. For more information, please visit istockphoto.com.
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 0149-5992
EISSN 1935-5548
In this Issue
Perspectives in Care
Latent Autoimmune Diabetes of Adults (LADA) Is Likely to Represent a Mixed Population of Autoimmune (Type 1) and Nonautoimmune (Type 2) Diabetes
Diabetes Care June 2021, Vol.44, 1243-1251. doi:https://doi.org/10.2337/dc20-2834
Commentary
Glucagon-Like Peptide 1 Receptor Agonists, Carotid Atherosclerosis, and Cardiovascular Outcomes
Diabetes Care June 2021, Vol.44, 1252-1253. doi:https://doi.org/10.2337/dci20-0076
Clinical Care / Education/Nutrition / Psychosocial Research
Frequency of Interruptions to Sitting Time: Benefits for Postprandial Metabolism in Type 2 Diabetes
Ashleigh R. Homer; Frances C. Taylor; Paddy C. Dempsey; Michael J. Wheeler; Parneet Sethi; Melanie K. Townsend; Megan S. Grace; Daniel J. Green; Neale D. Cohen; Robyn N. Larsen; Bronwyn A. Kingwell; Neville Owen; David W. Dunstan
Diabetes Care June 2021, Vol.44, 1254-1263. doi:https://doi.org/10.2337/dc20-1410
Spouse’s Diabetes Status and Incidence of Depression and Anxiety: An 18-Year Prospective Study
Diabetes Care April 2021, Vol.44, 1264-1272. doi:https://doi.org/10.2337/dc20-2652
Cognitive Function in Adolescents and Young Adults With Youth-Onset Type 1 Versus Type 2 Diabetes: The SEARCH for Diabetes in Youth Study
Allison L.B. Shapiro; Dana Dabelea; Jeanette M. Stafford; Ralph D’Agostino; Catherine Pihoker; Angela D. Liese; Amy S. Shah; Anna Bellatorre; Jean M. Lawrence; Leora Henkin; Sharon Saydah; Greta Wilkening; for the SEARCH for Diabetes in Youth Study Group
Diabetes Care June 2021, Vol.44, 1273-1280. doi:https://doi.org/10.2337/dc20-2308
Epidemiology / Health Services Research
Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19: An International, Multicenter Retrospective Meta-analysis
Danielle K. Longmore; Jessica E. Miller; Siroon Bekkering; Christoph Saner; Edin Mifsud; Yanshan Zhu; Richard Saffery; Alistair Nichol; Graham Colditz; Kirsty R. Short; David P. Burgner; International BMI-COVID consortium
Diabetes Care April 2021, Vol.44, 1281-1290. doi:https://doi.org/10.2337/dc20-2676
Renal Replacement Therapy in People With and Without Diabetes in Germany, 2010–2016: An Analysis of More Than 25 Million Inhabitants
Heiner Claessen; Maria Narres; Tatjana Kvitkina; Adrian Wilk; Heiko Friedel; Christian Günster; Falk Hoffmann; Michael Koch; Karin Jandeleit-Dahm; Andrea Icks
Diabetes Care June 2021, Vol.44, 1291-1299. doi:https://doi.org/10.2337/dc20-2477
Trends in Receipt of American Diabetes Association Guideline-Recommended Care Among U.S. Adults With Diabetes: NHANES 2005–2018
Jung-Im Shin; Dan Wang; Gail Fernandes; Natalie Daya; Morgan E. Grams; Sherita H. Golden; Swapnil Rajpathak; Elizabeth Selvin
Diabetes Care April 2021, Vol.44, 1300-1308. doi:https://doi.org/10.2337/dc20-2541
Genetic Risk Factors for CVD in Type 1 Diabetes: The DCCT/EDIC Study
Ionut Bebu; Sareh Keshavarzi; Xiaoyu Gao; Barbara H. Braffett; Angelo J. Canty; William H. Herman; Trevor J. Orchard; Samuel Dagogo-Jack; David M. Nathan; John M. Lachin; Andrew D. Paterson; on behalf of the DCCT/EDIC Research Group
Diabetes Care April 2021, Vol.44, 1309-1316. doi:https://doi.org/10.2337/dc20-2388
Incremental Dental Expenditures Associated With Diabetes Among Noninstitutionalized U.S. Adults Aged ≥18 Years Old in 2016–2017
Diabetes Care June 2021, Vol.44, 1317-1323. doi:https://doi.org/10.2337/dc20-2744
Emerging Therapies: Drugs and Regimens
Efficacy and Safety of Mulberry Twig Alkaloids Tablet for the Treatment of Type 2 Diabetes: A Multicenter, Randomized, Double-Blind, Double-Dummy, and Parallel Controlled Clinical Trial
Ling Qu; Xiaochun Liang; Guoqing Tian; Gaili Zhang; Qunli Wu; Xiumei Huang; Yazhong Cui; Yuling Liu; Zhufang Shen; Changqing Xiao; Yingfen Qin; Heng Miao; Yongyan Zhang; Ziling Li; Shandong Ye; Xuezhi Zhang; Jing Yang; Guiwen Cao; Yi Li; Gangyi Yang; Ji Hu; Xiaoyue Wang; Zhengfang Li; Yukun Li; Xiuzhen Zhang; Guangde Zhang; Li Chen; Wenjin Hua; Ming Yu; Chunyan Lu; Xiaomei Zhang; Hong Jiang
Diabetes Care April 2021, Vol.44, 1324-1333. doi:https://doi.org/10.2337/dc20-2109
Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial
Yvo J.M. Op den Kamp; Marlies de Ligt; Bas Dautzenberg; Esther Kornips; Russell Esterline; Matthijs K.C. Hesselink; Joris Hoeks; Vera B. Schrauwen-Hinderling; Bas Havekes; Jan Oscarsson; Esther Phielix; Patrick Schrauwen
Diabetes Care April 2021, Vol.44, 1334-1343. doi:https://doi.org/10.2337/dc20-2887
Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes
Diabetes Care April 2021, Vol.44, 1344-1352. doi:https://doi.org/10.2337/dc20-1794
Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial
Dario Giugliano; Miriam Longo; Paola Caruso; Rosa Di Fraia; Lorenzo Scappaticcio; Maurizio Gicchino; Michela Petrizzo; Giuseppe Bellastella; Maria Ida Maiorino; Katherine Esposito
Diabetes Care April 2021, Vol.44, 1353-1360. doi:https://doi.org/10.2337/dc20-2623
Dasiglucagon—A Next-Generation Glucagon Analog for Rapid and Effective Treatment of Severe Hypoglycemia: Results of Phase 3 Randomized Double-Blind Clinical Trial
Thomas R. Pieber; Ronnie Aronson; Ulrike Hövelmann; Julie Willard; Leona Plum-Mörschel; Kim M. Knudsen; Benedikte Bandak; Ramin Tehranchi
Diabetes Care April 2021, Vol.44, 1361-1367. doi:https://doi.org/10.2337/dc20-2995
Emerging Technologies: Data Systems and Devices
Important Drop in Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study
Ronan Roussel; Jean-Pierre Riveline; Eric Vicaut; Gérard de Pouvourville; Bruno Detournay; Corinne Emery; Fleur Levrat-Guillen; Bruno Guerci
Diabetes Care April 2021, Vol.44, 1368-1376. doi:https://doi.org/10.2337/dc20-1690
Pathophysiology / Complications
ACE I/D Polymorphism, Plasma ACE Levels, and Long-term Kidney Outcomes or All-Cause Death in Patients With Type 1 Diabetes
Yawa Abouleka; Kamel Mohammedi; Charlyne Carpentier; Severine Dubois; Pierre Gourdy; Jean-François Gautier; Ronan Roussel; André Scheen; François Alhenc-Gelas; Samy Hadjadj; Gilberto Velho; Michel Marre
Diabetes Care April 2021, Vol.44, 1377-1384. doi:https://doi.org/10.2337/dc20-3036
Cardiovascular and Metabolic Risk
The Effect of Exenatide Once Weekly on Carotid Atherosclerosis in Individuals With Type 2 Diabetes: An 18-Month Randomized Placebo-Controlled Study
Diabetes Care January 2021, Vol.44, 1385-1392. doi:https://doi.org/10.2337/dc20-2014
Alcohol Abstinence and the Risk of Atrial Fibrillation in Patients With Newly Diagnosed Type 2 Diabetes Mellitus: A Nationwide Population-Based Study
You-jung Choi; Kyung-Do Han; Eue-Keun Choi; Jin-Hyeung Jung; So-Ryoung Lee; Seil Oh; Gregory Y.H. Lip
Diabetes Care April 2021, Vol.44, 1393-1401. doi:https://doi.org/10.2337/dc20-2607
Autoantibodies Against Methylglyoxal-Modified Apolipoprotein B100 and ApoB100 Peptide Are Associated With Less Coronary Artery Atherosclerosis and Retinopathy in Long-Term Type 1 Diabetes
Kari Anne Sveen; Kristine Bech Holte; Mona Svanteson; Kristian F. Hanssen; Jan Nilsson; Eva Bengtsson; Tore Julsrud Berg
Diabetes Care April 2021, Vol.44, 1402-1409. doi:https://doi.org/10.2337/dc20-2089
A Type 2 Diabetes Subtype Responsive to ACCORD Intensive Glycemia Treatment
Arshiya Mariam; Galen Miller-Atkins; Kevin M. Pantalone; Robert S. Zimmerman; John Barnard; Michael W. Kattan; Hetal Shah; Howard L. McLeod; Alessandro Doria; Michael J. Wagner; John B. Buse; Alison A. Motsinger-Reif; Daniel M. Rotroff
Diabetes Care April 2021, Vol.44, 1410-1418. doi:https://doi.org/10.2337/dc20-2700
Biochemical Urine Testing of Medication Adherence and Its Association With Clinical Markers in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT)
Jelle M. Beernink; Milou M. Oosterwijk; Kamlesh Khunti; Pankaj Gupta; Prashanth Patel; Job F.M. van Boven; Hiddo J. Lambers Heerspink; Stephan J.L. Bakker; Gerjan Navis; Roos M. Nijboer; Gozewijn D. Laverman
Diabetes Care April 2021, Vol.44, 1419-1425. doi:https://doi.org/10.2337/dc20-2533
Associations of Type 2 Diabetes Onset Age With Cardiovascular Disease and Mortality: The Kailuan Study
Maoxiang Zhao; Lulu Song; Lan Sun; Miao Wang; Chi Wang; Siyu Yao; Yao Li; Cuijuan Yun; Sijin Zhang; Yizhen Sun; Ziwei Hou; Shouling Wu; Hao Xue
Diabetes Care April 2021, Vol.44, 1426-1432. doi:https://doi.org/10.2337/dc20-2375
Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study
Rajaa Nahra; Tao Wang; Kishore M. Gadde; Jan Oscarsson; Michael Stumvoll; Lutz Jermutus; Boaz Hirshberg; Philip Ambery
Diabetes Care June 2021, Vol.44, 1433-1442. doi:https://doi.org/10.2337/dc20-2151
Novel Communications in Diabetes
Application of 2021 American Diabetes Association Glycemic Treatment Clinical Practice Recommendations in Primary Care
Diabetes Care June 2021, Vol.44, 1443-1446. doi:https://doi.org/10.2337/dc21-0013
The Rapid Transition to Telemedicine and Its Effect on Access to Care for Patients With Type 1 Diabetes During the COVID-19 Pandemic
Diabetes Care April 2021, Vol.44, 1447-1450. doi:https://doi.org/10.2337/dc20-2712
Spike in Diabetic Ketoacidosis Rates in Pediatric Type 2 Diabetes During the COVID-19 Pandemic
Diabetes Care June 2021, Vol.44, 1451-1453. doi:https://doi.org/10.2337/dc20-2733
Errata
Erratum. Relations Between Subclinical Disease Markers and Type 2 Diabetes, Metabolic Syndrome, and Incident Cardiovascular Disease: The Jackson Heart Study. Diabetes Care 2015;38:1082–1088
Vanessa Xanthakis; Jung Hye Sung; Tandaw E. Samdarshi; Alethea N. Hill; Solomon K. Musani; Mario Sims; Kamel A. Gharaibeh; Philip R. Liebson; Herman A. Taylor; Ramachandran S. Vasan; Ervin R. Fox
Diabetes Care June 2021, Vol.44, 1455. doi:https://doi.org/10.2337/dc21-er06a
Erratum. Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis. Diabetes Care 2021;44:1062–1069
Vasudha Ahuja; Pasi Aronen; T.A. Pramodkumar; Helen Looker; Angela Chetrit; Aini H. Bloigu; Auni Juutilainen; Cristina Bianchi; Lucia La Sala; Ranjit Mohan Anjana; Rajendra Pradeepa; Ulagamadesan Venkatesan; Sarvanan Jebarani; Viswanathan Baskar; Teresa Vanessa Fiorentino; Patrick Timpel; Ralph A. DeFronzo; Antonio Ceriello; Stefano Del Prato; Muhammad Abdul-Ghani; Sirkka Keinänen-Kiukaanniemi; Rachel Dankner; Peter H. Bennett; William C. Knowler; Peter Schwarz; Giorgio Sesti; Rie Oka; Viswanathan Mohan; Leif Groop; Jaakko Tuomilehto; Samuli Ripatti; Michael Bergman; Tiinamaija Tuomi
Diabetes Care June 2021, Vol.44, 1457. doi:https://doi.org/10.2337/dc21-er06c
Issues and Events
e-Letters
Observations
Is Shelter-in-Place Policy Related to Mail Order Pharmacy Use and Racial/Ethnic Disparities for Patients With Diabetes?
Tainayah W. Thomas; Wendy T. Dyer; Maher Yassin; Romain Neugebauer; Andrew J. Karter; Julie A. Schmittdiel
Diabetes Care April 2021, Vol.44, e113-e114. doi:https://doi.org/10.2337/dc20-2686
Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes
Tadashi Imafuku; Hiroshi Watanabe; Kentaro Oniki; Akira Yoshida; Hiromasa Kato; Takehiro Nakano; Kai Tokumaru; Issei Fujita; Nanaka Arimura; Hitoshi Maeda; Yuki Sakamoto; Nozomi Kondo; Ayami Morita; Junji Saruwatari; Motoko Tanaka; Kazutaka Matsushita; Takashi Wada; Masafumi Fukagawa; Masaki Otagiri; Michael L. Fitzgerald; Hideaki Jinnouchi; Toru Maruyama
Diabetes Care April 2021, Vol.44, e115-e117. doi:https://doi.org/10.2337/dc20-3003
Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting
Luz E. Castellanos; Courtney A. Balliro; Jordan S. Sherwood; Rabab Jafri; Mallory A. Hillard; Evelyn Greaux; Rajendranath Selagamsetty; Hui Zheng; Firas H. El-Khatib; Edward R. Damiano; Steven J. Russell
Diabetes Care June 2021, Vol.44, e118-e120. doi:https://doi.org/10.2337/dc20-1086
Inequity in Racial-Ethnic Representation in Randomized Controlled Trials of Diabetes Technologies in Type 1 Diabetes: Critical Need for New Standards
Diabetes Care June 2021, Vol.44, e121-e123. doi:https://doi.org/10.2337/dc20-3063
Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor–Treated Type 2 Diabetes
Peter S. Hamblin; Rosemary Wong; Elif I. Ekinci; Shoshana Sztal-Mazer; Shananthan Balachandran; Aviva Frydman; Timothy P. Hanrahan; Raymond Hu; Shara N. Ket; Alan Moss; Mark Ng; Sashikala Ragunathan; Leon A. Bach
Diabetes Care April 2021, Vol.44, e124-e126. doi:https://doi.org/10.2337/dc21-0256
Cigarette Smoking as a Predictor of Sodium–Glucose Cotransporter 2 Inhibitor–Associated Genital Infections: A Retrospective Cohort Study
Diabetes Care April 2021, Vol.44, e127-e128. doi:https://doi.org/10.2337/dc21-0308
The Risks of Polycystic Ovary Syndrome and Diabetes Vary by Ethnic Subgroup Among Young Asian Women
Diabetes Care June 2021, Vol.44, e129-e130. doi:https://doi.org/10.2337/dc21-0373
The Prevalence of Food Insecurity Is Highest Among Americans for Whom Diet Is Most Critical to Health
Diabetes Care June 2021, Vol.44, e131-e132. doi:https://doi.org/10.2337/dc20-3116
Temporal Trends in Lower-Limb Major and Minor Amputation and Revascularization Procedures in People With Diabetes in England During the COVID-19 Pandemic
Jonathan Valabhji; Emma Barron; Eszter P. Vamos; Ketan Dhatariya; Frances Game; Partha Kar; Andy Weaver; Sophia Verma; Bob Young; Kamlesh Khunti
Diabetes Care June 2021, Vol.44, e133-e135. doi:https://doi.org/10.2337/dc20-2852
Comments and Responses
Response to Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care 2020;43:3007–3015
Ian J. Neeland; Takatoshi Kasai; Silvio E. Inzucchi; Brian S. Wojeck; Henry K. Yaggi; Odd Erik Johansen; on behalf of the EMPA-REG OUTCOME Investigators
Diabetes Care June 2021, Vol.44, e137-e138. doi:https://doi.org/10.2337/dci21-0009
Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901–907
Diabetes Care June 2021, Vol.44, e139. doi:https://doi.org/10.2337/dc21-0364
Response to Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901–907
Dorte Vistisen; Gregers S. Andersen; Adam Hulman; Stuart J. McGurnaghan; Helen M. Colhoun; Jan E. Henriksen; Reimar W. Thomsen; Frederik Persson; Peter Rossing; Marit E. Jørgensen
Diabetes Care June 2021, Vol.44, e140-e141. doi:https://doi.org/10.2337/dci21-0010
